N-(3,4-Dichlorophenyl)-5-phenyl-1,3,4-thiadiazol-2-amine

ID: ALA3785548

Chembl Id: CHEMBL3785548

PubChem CID: 127030350

Max Phase: Preclinical

Molecular Formula: C14H9Cl2N3S

Molecular Weight: 322.22

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Clc1ccc(Nc2nnc(-c3ccccc3)s2)cc1Cl

Standard InChI:  InChI=1S/C14H9Cl2N3S/c15-11-7-6-10(8-12(11)16)17-14-19-18-13(20-14)9-4-2-1-3-5-9/h1-8H,(H,17,19)

Standard InChI Key:  YHLKPOQMGQDUEV-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3785548

    ---

Associated Targets(non-human)

GUSB Beta-glucuronidase (291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus faecalis (29875 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 322.22Molecular Weight (Monoisotopic): 320.9894AlogP: 5.26#Rotatable Bonds: 3
Polar Surface Area: 37.81Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.16CX Basic pKa: 0.19CX LogP: 5.11CX LogD: 5.10
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.71Np Likeness Score: -2.25

References

1. Salar U, Taha M, Ismail NH, Khan KM, Imran S, Perveen S, Wadood A, Riaz M..  (2016)  Thiadiazole derivatives as New Class of β-glucuronidase inhibitors.,  24  (8): [PMID:26994638] [10.1016/j.bmc.2016.03.020]
2. Awolade P, Cele N, Kerru N, Gummidi L, Oluwakemi E, Singh P..  (2020)  Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.,  187  [PMID:31835168] [10.1016/j.ejmech.2019.111921]
3. Ameryckx A,Pochet L,Wang G,Yildiz E,Saadi BE,Wouters J,Van Bambeke F,Frédérick R.  (2020)  Pharmacomodulations of the benzoyl-thiosemicarbazide scaffold reveal antimicrobial agents targeting d-alanyl-d-alanine ligase in bacterio.,  200  [PMID:32497961] [10.1016/j.ejmech.2020.112444]

Source